ALNY - Alnylam Pharmaceuticals Inc. (ALNY) CEO John Maraganore on Q2 2021 Results - Earnings Call Transcript
Alnylam Pharmaceuticals, Inc. Q2 2021 Earnings Conference Call Aug 3, 2021 8:30 AM ET Company Participants Christine Lindenboom - Investor Relations John Maraganore - Chief Executive Officer Tolga Tanguler - Chief Commercial Officer Akshay Vaishnaw - President of Research and Development Jeff Poulton - Chief Financial Officer Yvonne Greenstreet - President and Chief Operating Officer Conference Call Participants Gena Wang - Barclays Alethia Young - Cantor Fitzgerald Maury Raycroft - Jefferies Salveen Richter - Goldman Sachs Paul Matteis - Stifel Ritu Baral - Cowen Tazeen Ahmad - Bank of America Mani Foroohar - SVB Leerink Luca Issi - RBC Presentation Operator Ladies and gentlemen, thank you for standing by. And welcome to the Alnylam Pharmaceuticals Q2 2021 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] I'd now like to turn the call over to
For further details see:
Alnylam Pharmaceuticals, Inc. (ALNY) CEO John Maraganore on Q2 2021 Results - Earnings Call Transcript